Rhumbline Advisers Zai Lab LTD Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Zai Lab LTD stock. As of the latest transaction made, Rhumbline Advisers holds 2,255 shares of ZLAB stock, worth $56,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,255
Previous 2,432
7.28%
Holding current value
$56,059
Previous $38,000
2.63%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ZLAB
# of Institutions
117Shares Held
40.9MCall Options Held
63.1KPut Options Held
420K-
Wellington Management Group LLP Boston, MA7.12MShares$177 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$162 Million0.06% of portfolio
-
Capital World Investors Los Angeles, CA5.31MShares$132 Million0.02% of portfolio
-
Woodline Partners LP San Francisco, CA2.33MShares$58 Million0.41% of portfolio
-
Viking Global Investors LP2.04MShares$50.6 Million0.14% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.43B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...